TORVANTA
Other · S&P 500 · data as of 2026-10-05

VIR stock analysis: VIR

VIR (VIR) is an S&P 500 company in Other. It grades strongest on momentum and weakest on profitability.

The model's view of VIR · subscribers

Where VIR ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with VIR · updated 2026-10-05 · from prices and SEC filings

VIR price performance

VIR against the S&P 500, one year
+0%+50%+100%VIR +109%S&P 500 +18%2025-09-292026-10-05
Year to date+95.4%S&P 500 +14.5% · ahead by 80.8 pts
1 year+105.6%S&P 500 +17.0% · ahead by 88.6 pts
3 years+31.3%S&P 500 +89.3% · behind by 57.9 pts
5 years-66.6%S&P 500 +91.3% · behind by 157.9 pts

Total returns with dividends reinvested.

VIR factor grades

Each grade compares VIR with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

–ValueFCF yield -10.2% (industry 6.0%)
–Growth
FProfitabilityOperating margin -92.4% (industry 9.6%)ROIC -31.5% (industry 10.1%)
AMomentum12-month change +106%From 52-wk high 0%

VIR in plain numbers

VIR key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$2.0B
Revenue growth (y/y)+1496%
Free-cash-flow yield-10.2%
Dividend yieldn/a
Next earnings (expected)2026-11-04
Valuation measures
Market value$2.0B
Enterprise value$1.7B
Price / sales6.6x
Price / book2.0x
EV / revenue5.7x
Financial highlights
Revenue, last 12 months$303.2M
Net income, last 12 months-$251.7M
EPS, last 12 months (GAAP)$-1.85
Operating margin-92.4%
Net margin-83.0%
Return on equity-26.1%
Return on invested capital-31.5%
Cash$278.7M
Total debt$0
Free cash flow, last 12 months-$203.6M
Current ratio6.04x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

VIR earnings trends

Revenue vs earnings
-$213.7M-$100.6M$12.6M$125.8M$238.9MSep 2024 Revenue: $2.4MDec 2024 Revenue: $12.4MMar 2025 Revenue: $3.0MJun 2025 Revenue: $1.2MSep 2025 Revenue: $240KDec 2025 Revenue: $64.1MMar 2026 Revenue: -$29KJun 2026 Revenue: $238.9MSep 2024 Net income: -$213.7MDec 2024 Net income: -$104.6MMar 2025 Net income: -$121.0MJun 2025 Net income: -$111.0MSep 2025 Net income: -$163.1MDec 2025 Net income: -$42.9MMar 2026 Net income: -$125.7MJun 2026 Net income: $80.1MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: -8979.7%Net margin: -845.2%Net margin: -3989.6%Net margin: -9139.9%Net margin: -67975.4%Net margin: -67.0%Net margin: 433431.0%Net margin: 33.5%-67975%182728%433431%■ Revenue ■ Net income ━ Net margin
Earnings per share$-1.6$-1.1$-0.5$-0.0$0.5Sep 2024 EPS (GAAP, diluted): $-1.6Dec 2024 EPS (GAAP, diluted): $-0.8Mar 2025 EPS (GAAP, diluted): $-0.9Jun 2025 EPS (GAAP, diluted): $-0.8Sep 2025 EPS (GAAP, diluted): $-1.2Dec 2025 EPS (GAAP, diluted): $-0.3Mar 2026 EPS (GAAP, diluted): $-0.9Jun 2026 EPS (GAAP, diluted): $0.5Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted)

From the company's 10-Q and 10-K filings with the SEC.

VIR financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$1.1B$1.6B$86.2M$74.2M$68.6M
Net income$528.6M$515.8M-$615.1M-$522.0M-$438.0M
EPS (GAAP)$3.90$3.82$-4.59$-3.82$-3.15
Free cash flow-$69.4M$1.6B-$800.4M-$453.7M-$396.6M

VIR earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-08-05$0.47n/a+19583%-4.1%
2026-05-06$-0.85n/a-101%-8.5%
2026-02-23$-0.30n/a+418%+25.8%
2026-01-12$-0.30n/a+418%+7.9%
2025-11-05$-1.17n/a-90%-1.8%
2025-08-06$-0.80n/a-61%-15.6%

About VIR

HeadquartersSan Francisco, CA
Industry (SEC code)Biological Products, (No Diagnostic Substances)
Fiscal year endsDecember 31
Incorporated inDE
Listed onNasdaq

From the company's SEC registration record.

Companies similar to VIR

CompanyMarket valueP/ERevenue growthOperating margin12-month change
VIR VIR$2.0Bn/an/a-92.4%+106%
WS WS$2.0B244.5x+11%-0.0%+26%compare
INVX INVX$2.0B31.9x+15%10.0%+51%compare
NWN NWN$2.0B15.6x+4%22.8%+11%compare
PGNY PGNY$2.0B28.1x+6%8.6%+26%
PRGO PRGO$2.0Bn/a-4%-37.7%-30%
FTRE FTRE$2.0Bn/a-2%-0.4%+123%

All Other stock ratings

Frequently asked questions

Is VIR stock a buy?

Torvanta does not tell individuals what to buy. Its grades for VIR are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

When does VIR report earnings next?

Based on its filing history, Torvanta expects VIR to report around 2026-11-04.

How has VIR performed against the S&P 500?

Over the past year VIR returned +105.6%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer